Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. (Q48384000)

11 February 2018

title

Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. (English)

1 reference

11 February 2018

author name string

Y Yang

1

1 reference

11 February 2018

A Shuaib

2

1 reference

11 February 2018

Q Li

3

1 reference

11 February 2018

M M Siddiqui

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

11 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

11 February 2018

volume

804

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

169-176

1 reference

11 February 2018

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

7 January 2021

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Cellular Origins of Endogenous Amino Acids Released into the Extracellular Fluid of the Rat Striatum During Severe Insulin-Induced Hypoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Intracerebral haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Intra-arterial thrombolysis in acute ischaemic stroke: experience with a superselective catheter embedded in the clot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Brain calcium content in ischemic infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

"Brain attack": an indication for thrombolysis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Kynurenate inhibition of cell excitation decreases stroke size and deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Limiting ischemic injury by inhibition of excitatory amino acid release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Effects of excitatory and inhibitory amino acid agonists and antagonists of ventral horn cells in slices of spinal cord isolated from adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Failure of MK-801 to reduce infarct volume in thrombotic middle cerebral artery occlusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Update on the mechanism of action of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Gamma-aminobutyric acid and nervous system function--a perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Characterization of the exocytotic release of glutamate from guinea-pig cerebral cortical synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Practical aspects of the use of topiramate in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

GABA agonist "muscimol" is neuroprotective in repetitive transient forebrain ischemia in gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Clomethiazole protects the brain in transient forebrain ischemia when used up to 4 h after the insult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Topiramate: a new antiepileptic drug for refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Topiramate: a potent anticonvulsant in the amygdala-kindled rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

A new rat model of thrombotic focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900410-7

10.1016/S0006-8993(98)00410-7

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9757028

1 reference

11 February 2018